Immutep Limited
-
Ticker
IMMP
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 11-50 Employees
- Based in Sydney, Australia
Immutep is a globally active biotechnology company, listed on the Australian Stock Exchange and on the NASDAQ Global Market in the US. As a leader in personalized bio-therapeutic products for cancer, Immutep is dedicated to leveraging its current technology and expertise to develop innovative treatment options for patients and maximize value to shareholders.
Immutep Limited
Most Recent Responsibility Report
MOST RECENT
2023 Environmental Social and
Governance (ESG) Report
Our service enables potential investors to review the most recent and archived Immutep Limited Sustainability Report, Immutep Limited Corporate Social Responsibility Report, Immutep Limited CSR Report, Immutep Limited Corporate Responsibility, Immutep Limited CR Report, Immutep Limited Citizenship Report, Immutep Limited ESG Report, and Immutep Limited Environmental Report online.